Holen Sie sich die Stockscreener-App
34.45
0.35%
-0.12
Schlusskurs vom Vortag:
$34.57
Offen:
$34.25
24-Stunden-Volumen:
6.30M
Relative Volume:
1.00
Marktkapitalisierung:
$16.94B
Einnahmen:
$194.78B
Nettoeinkommen (Verlust:
$-6.68B
KGV:
-2.529
EPS:
-13.6221
Netto-Cashflow:
$4.32B
1W Leistung:
-21.08%
1M Leistung:
-15.11%
6M Leistung:
+3.58%
1J Leistung:
-40.56%
1-Tages-Spanne:
$34.18
$34.97
1-Wochen-Bereich:
$33.85
$43.82
52-Wochen-Spanne:
$25.07
$66.03
Centene Corp Stock (CNC) Company Profile
Firmenname
Centene Corp
Sektor
Branche
Telefon
(314) 725-4477
Adresse
7700 FORSYTH BLVD., ST LOUIS
Compare CNC vs UNH, CVS, CI, ELV, HUM
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CNC
Centene Corp
|
34.45 | 16.94B | 194.78B | -6.68B | 4.32B | -13.62 |
|
UNH
Unitedhealth Group Inc
|
282.09 | 256.05B | 447.57B | 12.81B | 16.08B | 13.19 |
|
CVS
Cvs Health Corp
|
76.13 | 96.85B | 402.11B | 1.73B | 7.81B | 1.3835 |
|
CI
Cigna Group
|
267.19 | 70.41B | 274.88B | 6.29B | 8.39B | 22.19 |
|
ELV
Elevance Health Inc
|
291.63 | 64.36B | 199.13B | 5.66B | 3.17B | 25.11 |
|
HUM
Humana Inc
|
165.43 | 19.86B | 126.36B | 1.30B | 1.55B | 10.67 |
Centene Corp Stock (CNC) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2026-01-05 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2025-10-14 | Eingeleitet | Goldman | Sell |
| 2025-07-28 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2025-07-23 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2025-07-21 | Herabstufung | TD Cowen | Buy → Hold |
| 2025-07-16 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2025-07-10 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2025-07-02 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2025-07-02 | Herabstufung | UBS | Buy → Neutral |
| 2025-06-09 | Fortgesetzt | Morgan Stanley | Overweight |
| 2025-06-02 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2025-04-08 | Hochstufung | Jefferies | Underperform → Hold |
| 2025-02-06 | Herabstufung | Argus | Buy → Hold |
| 2024-12-17 | Fortgesetzt | JP Morgan | Overweight |
| 2024-12-13 | Hochstufung | UBS | Neutral → Buy |
| 2024-12-10 | Herabstufung | Jefferies | Hold → Underperform |
| 2024-07-24 | Herabstufung | Jefferies | Buy → Hold |
| 2024-05-30 | Eingeleitet | Robert W. Baird | Neutral |
| 2024-03-21 | Herabstufung | Stephens | Overweight → Equal-Weight |
| 2024-03-06 | Eingeleitet | Barclays | Overweight |
| 2024-01-02 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2023-09-05 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2023-08-30 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2023-07-12 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2023-06-20 | Eingeleitet | UBS | Neutral |
| 2023-04-21 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-03-08 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2023-02-23 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2022-12-13 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2022-09-30 | Eingeleitet | Argus | Buy |
| 2022-08-26 | Herabstufung | Wells Fargo | Overweight → Equal Weight |
| 2022-07-28 | Fortgesetzt | Barclays | Overweight |
| 2022-07-14 | Hochstufung | Jefferies | Hold → Buy |
| 2022-06-21 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2022-06-17 | Eingeleitet | Loop Capital | Buy |
| 2022-05-27 | Fortgesetzt | Bernstein | Outperform |
| 2022-05-26 | Herabstufung | BofA Securities | Buy → Neutral |
| 2022-01-07 | Fortgesetzt | Barclays | Overweight |
| 2022-01-06 | Fortgesetzt | JP Morgan | Overweight |
| 2021-12-14 | Eingeleitet | Goldman | Neutral |
| 2021-12-13 | Bestätigt | BMO Capital Markets | Outperform |
| 2021-12-13 | Bestätigt | BofA Securities | Buy |
| 2021-12-13 | Bestätigt | Credit Suisse | Neutral |
| 2021-12-13 | Bestätigt | Mizuho | Neutral |
| 2021-12-13 | Bestätigt | Oppenheimer | Outperform |
| 2021-12-13 | Bestätigt | Stephens | Overweight |
| 2021-12-13 | Bestätigt | Truist | Buy |
| 2021-12-13 | Bestätigt | Wells Fargo | Overweight |
| 2021-12-13 | Bestätigt | Wolfe Research | Outperform |
| 2021-11-01 | Herabstufung | Citigroup | Buy → Neutral |
| 2021-09-10 | Eingeleitet | Cowen | Outperform |
| 2021-07-09 | Eingeleitet | Seaport Global Securities | Buy |
| 2021-05-19 | Eingeleitet | Wells Fargo | Overweight |
| 2021-05-11 | Hochstufung | Stephens | Equal-Weight → Overweight |
| 2021-03-10 | Eingeleitet | Mizuho | Neutral |
| 2021-01-21 | Fortgesetzt | Goldman | Neutral |
| 2021-01-15 | Herabstufung | Jefferies | Buy → Hold |
| 2020-09-22 | Herabstufung | Stephens | Overweight → Equal-Weight |
| 2020-07-01 | Eingeleitet | SVB Leerink | Outperform |
| 2020-02-05 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2020-02-03 | Fortgesetzt | Evercore ISI | Outperform |
| 2020-01-28 | Bestätigt | Bernstein | Outperform |
| 2020-01-06 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2019-09-12 | Eingeleitet | Deutsche Bank | Buy |
| 2019-05-10 | Hochstufung | Citigroup | Neutral → Buy |
| 2019-01-14 | Eingeleitet | Stephens | Overweight |
| 2018-10-24 | Hochstufung | Leerink Partners | Mkt Perform → Outperform |
| 2018-07-18 | Fortgesetzt | Citigroup | Neutral |
| 2017-12-18 | Bestätigt | Jefferies | Buy |
| 2017-09-13 | Bestätigt | Leerink Partners | Mkt Perform |
| 2017-06-07 | Eingeleitet | Morgan Stanley | Overweight |
| 2017-05-22 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2017-04-05 | Eingeleitet | Deutsche Bank | Buy |
| 2017-03-23 | Herabstufung | Citigroup | Buy → Neutral |
| 2017-02-08 | Bestätigt | Barclays | Overweight |
| 2017-02-07 | Fortgesetzt | Cantor Fitzgerald | Overweight |
| 2017-01-04 | Eingeleitet | Piper Jaffray | Overweight |
Alle ansehen
Centene Corp Aktie (CNC) Neueste Nachrichten
Centene, Paramount Skydance, And Ulta Beauty Are Among Top 10 Large Cap Losers Last Week (March 9-March 13): Are the Others in Your Portfolio? - Benzinga
Centene, Paramount Skydance, And Ulta Beauty Are Among Top 10 Large Cap Losers Last Week (March 9-March 13): Are the Others in Your Portfolio? - Benzinga
Centene (CNC) Leads Healthcare Losers with 21% Drop - GuruFocus
Clearline Capital LP Raises Stock Holdings in Centene Corporation $CNC - MarketBeat
Centene Corp. Stock (ISIN: US15133V1035) Faces Pressure Amid Institutional Buying and Analyst Cautio - AD HOC NEWS
Quinn Opportunity Partners LLC Has $5.39 Million Position in Centene Corporation $CNC - MarketBeat
Centene Confronts ACA Membership Slide And Tests AI Driven Cost Controls - Yahoo Finance
Centene Corp. stock underperforms Thursday when compared to competitors - MarketWatch
Centene (CNC) Valuation Check After Barclays Conference Selloff And ACA Marketplace Concerns - simplywall.st
Bernstein SocGen cuts Centene stock price target on 4Q results By Investing.com - Investing.com Nigeria
Bernstein SocGen cuts Centene stock price target on 4Q results - Investing.com
Zacks Industry Outlook Highlights UnitedHealth, The Cigna, Humana and Centene - The Globe and Mail
Zacks Industry Outlook Features UnitedHealth, The Cigna, Humana, and Centene - Bitget
Obamacare’s Slow Death Is Debilitating Centene Stock - Barchart.com
Mizuho Maintains Neutral Stance, Lowers Price Target on CNC | CN - GuruFocus
Centene (CNC) Shares Drop Over 10% - GuruFocus
Oracle, Nio, Centene, AeroVironment And Ciena Corporation: Why These 5 Stocks Are On Investors' Radars Today - Benzinga
Mizuho cuts Centene stock price target on exchange enrollment concerns By Investing.com - Investing.com Australia
Centene (CNC) Shares Plummet Amid ACA Challenges - GuruFocus
Is Centene Stock Underperforming the Nasdaq? - Barchart.com
Centene tumbles on ACA warnings but leads managed care with top Buy Quant rating (CNC:NYSE) - Seeking Alpha
Mizuho cuts Centene stock price target on exchange enrollment concerns - Investing.com Nigeria
Why Is Centene Stock Falling On Tuesday? - Bitget
U.S. Indexes Finished Mixed Tuesday As BridgeBio Pharma Led, Centene Lagged - Barron's
Centene Corporation Files Form 8-K with SEC: Company Details, Stock Information, and Filing Data (March 10, 2026) - Minichart
Centene (NYSE:CNC) Trading Down 10.3%What's Next? - MarketBeat
Dow Jumps Over 300 Points; Kohl's Posts Upbeat Earnings - Benzinga
Centene Corp (CNC) Trading Down 11.57% on Mar 10 - GuruFocus
Centene (CNC) Shares Plummet Amid ACA Membership Concerns - GuruFocus
Centene shares fall as health insurer sees steeper drop in Obamacare memberships - Reuters
Centene (CNC) Shares Plunge Amid Market Dynamics - GuruFocus
Centene at Barclays Healthcare Conference: Strategic Adjustments and Future Plans - Investing.com
Centene Corporation (CNC) Announces Participation in Barclays Gl - GuruFocus
Centene (CNC) Targets 3.5 Million Members Amid Rising Specialty Pharmacy Demand - GuruFocus
Centene (CNC) Reaffirms 2026 Earnings Guidance at Healthcare Con - GuruFocus
Centene Corp reaffirms 2026 GAAP diluted EPS guidance of over $1.98 and adjusted EPS of over $3.00 - marketscreener.com
Centene Faces Big Headwinds Through 2027 in Its Target Markets - Morningstar
Centene Corporation (NYSE:CNC) Given Average Recommendation of "Hold" by Analysts - MarketBeat
Centene Corp. stock outperforms competitors on strong trading day - MSN
CNC Stock Price, Quote & Chart | CENTENE CORP (NYSE:CNC) - ChartMill
Centene Corporation $CNC Position Increased by Focus Partners Advisor Solutions LLC - MarketBeat
A Glimpse Into The Expert Outlook On Centene Through 5 Analysts - Benzinga
Centene (CNC) Receives Analyst Rating Update and PT Raise from M - GuruFocus
What Centene (CNC)'s Margin Improvement Outlook Means For Shareholders - simplywall.st
Centene Corp. stock underperforms Tuesday when compared to competitors - MarketWatch
Health Net’s $31.25M bet on housing aims to steady 900 CA families - Stock Titan
3 Reasons CNC is Risky and 1 Stock to Buy Instead - Finviz
Mitsubishi UFJ Asset Management Co. Ltd. Purchases 52,279 Shares of Centene Corporation $CNC - MarketBeat
DNB Asset Management AS Purchases 141,458 Shares of Centene Corporation $CNC - MarketBeat
Centene Corp stock: Why Wall Street is suddenly watching your health plan - AD HOC NEWS
Will Reaffirmed 2026 EPS Guidance and Stronger Medicaid Margins Change Centene’s (CNC) Narrative - Yahoo Finance
Finanzdaten der Centene Corp-Aktie (CNC)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.08%
0.76%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):